Visit www.aliveraw.com today! Dr. Clement tells us about treating Crohn’s Disease.

Research teams led by Mayo Clinic have demonstrated that stool DNA testing may be useful for detection of premalignant dysplasia in patients with inflammatory bowel disease (IBD). The findings were presented at Digestive Disease Week 2010, the annual meeting of the American Gastroenterological Association. David Ahlquist, MD, a gastroenterologist with Mayo Clinic and the senior investigator, said that sensitive stool DNA test methods developed at Mayo Clinic can detect common forerunners of colorectal cancer. Detection of precursor lesions during screening is essential if cancer prevention is the goal, Dr. Ahlquist says. Compared to widely used fecal blood tests, stool DNA testing has higher detection rates for curable stage colorectal cancer and for common precancerous polyps (called adenomas). The study, presented on May 3 at Digestive Disease Week, involves identifying both cancer and a precancerous lesion, called dysplasia, in people who suffer from IBD. In a blinded study with 10 cases and 10 controls done in conjunction with Mount Sinai Medical Center and the University of Chicago, researchers found that stool DNA testing was positive in nine out of 10 cases (five of five with cancer, and four of five with dysplasia). This study shows that cancer and pre-cancer in IBD can be detected noninvasively, says Dr. Ahlquist. The 90 percent detection rate by stool DNA testing is remarkable. Its important for people with IBD because they are at much higher risk for colorectal …

Crohns Disease patient’s testimony of being able to live an almost normal life after trying low dosage medical marijuana capsules. He can now sleep throughout the night and work without the pain and severe symptoms of the disease and drugs prescribed for the disease.

Keith suffers from Crohn’s Disease. He currently takes SEROVERA AMP 500 to remain in remission. To learn more about SEROVERA AMP 500, please visit www.serovera.co.uk. Crohn’s Disease: Crohn’s disease can occur anywhere in the digestive tract and may recur over the course of a lifetime. Crohn’s disease, which affects between 500000 and two million individuals in the United States, is a chronic inflammation of the digestive tract, most commonly affecting the last part of the small intestine and/or the large intestine (colon). Crohn’s disease also may be called ileitis or enteritis. Crohn’s disease can be difficult to diagnose because its symptoms are similar to those of other intestinal disorders, such as irritable bowel syndrome and ulcerative colitis.

my first remicade treamtent for corhns disease went very well! watch this cideo for details. more to come videos to come and i will be having another treatment in 2 weeks